Sift Biosciences
Phase 1Using AI to decode nature’s signals to guide the next generation of immunotherapy development.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $3.2M
About
Using AI to decode nature’s signals to guide the next generation of immunotherapy development.
Cell TherapyOncology
Funding History
1Total raised:$3.2M
Seed$3.2MJun 15, 2021